Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.2.1.22 (
cystathionine beta-synthase
)
965
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cystathionine beta-synthase
(
CBS
) catalyzes the condensation of serine and homocysteine to cystathionine, which represents the committing step in the transsulfuration pathway.
CBS
is unique in being a pyridoxal phosphate-dependent enzyme that has a heme cofactor. The activity of
CBS
under in vitro conditions is responsive to the redox state of the heme, which is distant from the active site and has been postulated to play a regulatory role. The heme in
CBS
is unusual; it is six-coordinate, low spin, and contains cysteine and histidine as axial ligands. In this study, we have assessed the redox behavior of a human
CBS
dimeric variant lacking the C-terminal regulatory domain. Potentiometric redox titrations showed a reversible response with a reduction potential of -291 +/- 5 mV versus the normal hydrogen electrode, at pH 7.2. Stopped-flow kinetic determinations demonstrated that Fe(II)
CBS
reacted with dioxygen yielding Fe(III)
CBS
without detectable formation of an intermediate species. A linear dependence of the apparent rate constant of Fe(II)
CBS
decay on dioxygen concentration was observed and yielded a second-order rate constant of (1.11 +/- 0.07) x 10 (5) M (-1) s (-1) at pH 7.4 and 25 degrees C for the direct reaction of Fe(II)
CBS
with dioxygen. A similar reactivity was observed for full-length
CBS
. Heme oxidation led to
superoxide radical
generation, which was detected by the superoxide dismutase (SOD)-inhibitable oxidation of epinephrine. Our results show that
CBS
may represent a previously unrecognized source of cytosolic
superoxide radical
.
...
PMID:Dioxygen reactivity and heme redox potential of truncated human cystathionine beta-synthase. 1827 72